There can be no assurance that the exploration of strategic alternatives will result in a transaction. The Company does not expect to make further public comment regarding these matters while its exploration process continues.
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, includingproduct and portfoliomanagement capabilities;commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.
A service of YellowBrix, Inc.
